Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)

被引：0
|
作者：
Qian, C. [1 ]
Wang, C. [2 ]
Wang, X. [2 ]
He, Q. [2 ]
Ma, T. [2 ]
Zhang, X. [2 ]
机构：
[1] Peoples Liberat Army Mil Med Univ, Affiliated Hosp 3, Daping Hosp, Dept Oncol, Chongqing, Peoples R China
[2] Genetron Hlth Beijing Co Ltd, Dept Translat Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002P
引用
收藏
页码：S1118 / S1118
页数：1
相关论文
共 50 条
  • [1] Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
    Jin, Xing
    Zheng, Yuansheng
    Chen, Zhencong
    Wang, Fei
    Bi, Guoshu
    Li, Ming
    Liang, Jiaqi
    Sui, Qihai
    Bian, Yunyi
    Hu, Zhengyang
    Qiao, Yulei
    Xu, Songtao
    CANCER MEDICINE, 2021, 10 (23): : 8673 - 8692
  • [2] Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma
    Zhang, Yongxing
    Fan, Hong
    Fang, Shuo
    Wang, Lin
    Chen, Li
    Jin, Yulin
    Jiang, Wei
    Lin, Zongwu
    Shi, Yu
    Zhan, Cheng
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : 1639 - +
  • [3] Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma
    Sheth, Siddharth
    Farquhar, Douglas R.
    Schrank, Travis P.
    Stepp, Wesley
    Mazul, Angela
    Hayward, Michele
    Lenze, Nicholas
    Little, Paul
    Jo, Heejoon
    Major, M. Ben
    Chera, Bhishamjit S.
    Zevallos, Jose P.
    Hayes, D. Neil
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2021, 6 (04): : 699 - 707
  • [4] Germline variation in NFE2L2/CUL3/KEAP1 and risk of head and neck squamous cell carcinoma (HNSCC)
    Sheth, Siddharth
    Weissfeld, Joel L.
    Romkes, Marjorie
    Ferris, Robert L.
    Grandis, Jennifer R.
    Bauman, Julie E.
    Diergaarde, Brenda
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer
    Hellyer, Jessica A.
    Stehr, Henning
    Das, Millie
    Padda, Sukhmani K.
    Ramchandran, Kavitha
    Neal, Joel W.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2019, 134 : 42 - 45
  • [6] KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
    Arolt, Christoph
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Scheel, Andreas H.
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Fler, Matthias Schef
    Hillmer, Axel M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : 1550 - 1567
  • [7] Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer
    Jeong, Youngtae
    Hellyer, Jessica A.
    Stehr, Henning
    Hoang, Ngoc T.
    Niu, Xiaomin
    Das, Millie
    Padda, Sukhmani K.
    Ramchandran, Kavitha
    Neal, Joel W.
    Wakelee, Heather
    Diehn, Maximilian
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 274 - 281
  • [8] Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis
    Bergstrom, Petra
    von Otter, Malin
    Nilsson, Staffan
    Nilsson, Ann-Charloth
    Nilsson, Michael
    Andersen, Peter M.
    Hammarsten, Ola
    Zetterberg, Henrik
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (1-2) : 130 - 137
  • [9] Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
    Arolt, Christoph
    Scheel, Andreas H.
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Scheffler, Matthias
    Hillmer, Axel M.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [10] Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
    Arolt, Christoph
    Calaminus, Andreas
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Scheffler, Matthias
    Hillmer, Axel
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 134 - 134
12345